Company / R&D per Share
Boston Scientific R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.37
FY2025
5-year range
$0.83 / $1.37
FY2021-FY2025
Trend
+26.3%
vs FY2024
Sector context
#62 of 108
Health Care
What the data says
At $1.37, Boston Scientific's r&d per share ranks #62 of 108 in the Health Care sector. R&D per Share has increased for 5 consecutive years, from $0.79 in FY2020 to $1.37 in FY2025.
Based on SEC 10-K filings.
1.37 in FY2025 with a 5-year CAGR of +11.6%.
Improved from $0.99 to $1.37 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +14.3%
- 5-Year CAGR
- +11.6%
- 10-Year CAGR
- -
Sector benchmark
#62 of 108 in Health CareTop 57% of 108This company $1.37 Sector average $2.07
▼
-33.7% below sector average
Key checks
Key Insights
- Boston Scientific's r&d per share has grown for 5 consecutive years.
- In FY2025, r&d per share increased 26.3% year-over-year.
- Ranks #62 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.37 | +26.3% |
| FY2024 | $1.09 | +10.2% |
| FY2023 | $0.99 | +7.3% |
| FY2022 | $0.92 | +10.4% |
| FY2021 | $0.83 | +4.8% |
| FY2020 | $0.79 | -5.6% |
| FY2019 | $0.84 | +4.7% |
| FY2018 | $0.80 | +10.7% |
| FY2017 | $0.73 | +6.3% |
| FY2016 | $0.68 | +3.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026